DrugDashboards

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate · DEXTROAMPHETAMINE SACCHARATE 2.5 mg/1; AMPHETAMINE ASPARTATE MONOHYDRATE 2.5 mg/1; DEXTROAMPHETAMINE SULFATE 2.5 mg/1; AMPHETAMINE SULFATE 2.5 mg/1 · Tablet · Oral · Sandoz Inc

NDC 00185-0842-01 · 100 TABLET in 1 BOTTLE · ANDA · View full market →

The short version

Just 2 companies supply this market — thin enough that a single exit would be felt immediately. The price is down 14% over the past year, to $0.2391 per unit. It is in shortage right now. Put together: worth watching — several of the pressures that precede supply trouble are present at once.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$0.2391per EAinvoice-surveyed acquisition cost · Aug 19, 2026
  • Federal contracts pay (FSS)$0.3522per unitSandoz, Inc. · Aug 15, 2023147% of what pharmacies pay — higher than 67% of drugs with this benchmark
  • Medicaid generic ceiling (FUL)$0.2391per TABweighted avg manufacturer price $0.1358 · Aug 1, 2026100% of what pharmacies pay — higher than 10% of drugs with this benchmark

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.25$0.5$0.75Aug 2016Sep 2026$0.2391
121 price points · per EA · dashed = manufacturer avg (WAMP)Source: CMS NADAC

Estimated fill cost

#30 count
$7.17
#90 count
$21.52

Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.

Medicaid spend (2025)

$4.6M
252,306 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

45Elevated risk

The score is counting real pressure here. One of these alone is routine; it’s the combination that makes this market worth watching.

  • 2 active manufacturers+20
  • in shortage now+25

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.2%chance of a new FDA shortage posting for dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate (oral solid) in the next 90 days

OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
ANDA040439
TE code
AB
Approval date
Jun 14, 2002
Patents / exclusivity
None on file

Shortage history

  • In shortage now Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 0185-2098-01)Oct 12, 2022
    month 47 — 3× the typical 14-month oral solid shortage · model puts 26% odds it resolves within 6 months
  • In shortage now Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 0185-0842-01)Oct 12, 2022
    month 47 — 3× the typical 14-month oral solid shortage · model puts 26% odds it resolves within 6 months
  • In shortage now Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 0185-0853-01)Oct 12, 2022
    month 47 — 3× the typical 14-month oral solid shortage · model puts 26% odds it resolves within 6 months
  • In shortage now Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 0185-2099-01)Oct 12, 2022
    month 47 — 3× the typical 14-month oral solid shortage · model puts 26% odds it resolves within 6 months

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate (Tablet)

LabelerStrengthFirst seenLast seen
Bryant Ranch PrepackDEXTROAMPHETAMINE SACCHARATE 2.5 mg/1; AMPHETAMINE ASPARTATE MONOHYDRATE 2.5 mg/1; DEXTROAMPHETAMINE SULFATE 2.5 mg/1; AMPHETAMINE SULFATE 2.5 mg/1Jul 22, 2026Sep 2, 2026
Bryant Ranch PrepackDEXTROAMPHETAMINE SACCHARATE 7.5 mg/1; AMPHETAMINE ASPARTATE MONOHYDRATE 7.5 mg/1; DEXTROAMPHETAMINE SULFATE 7.5 mg/1; AMPHETAMINE SULFATE 7.5 mg/1Jul 22, 2026Sep 2, 2026
Sandoz IncDEXTROAMPHETAMINE SACCHARATE 7.5 mg/1; AMPHETAMINE ASPARTATE MONOHYDRATE 7.5 mg/1; DEXTROAMPHETAMINE SULFATE 7.5 mg/1; AMPHETAMINE SULFATE 7.5 mg/1Jul 22, 2026Sep 2, 2026
Sandoz IncDEXTROAMPHETAMINE SACCHARATE 1.25 mg/1; AMPHETAMINE ASPARTATE MONOHYDRATE 1.25 mg/1; DEXTROAMPHETAMINE SULFATE 1.25 mg/1; AMPHETAMINE SULFATE 1.25 mg/1Jul 22, 2026Sep 2, 2026
Sandoz IncDEXTROAMPHETAMINE SACCHARATE 2.5 mg/1; AMPHETAMINE ASPARTATE MONOHYDRATE 2.5 mg/1; DEXTROAMPHETAMINE SULFATE 2.5 mg/1; AMPHETAMINE SULFATE 2.5 mg/1Jul 22, 2026Sep 2, 2026
Sandoz IncDEXTROAMPHETAMINE SACCHARATE 5 mg/1; AMPHETAMINE ASPARTATE MONOHYDRATE 5 mg/1; DEXTROAMPHETAMINE SULFATE 5 mg/1; AMPHETAMINE SULFATE 5 mg/1Jul 22, 2026Sep 2, 2026
Bryant Ranch PrepackAMPHETAMINE ASPARTATE MONOHYDRATE 2.5 mg/1; AMPHETAMINE SULFATE 2.5 mg/1; DEXTROAMPHETAMINE SACCHARATE 2.5 mg/1; DEXTROAMPHETAMINE SULFATE 2.5 mg/1Jul 15, 2026Jul 15, 2026
Bryant Ranch PrepackAMPHETAMINE ASPARTATE MONOHYDRATE 7.5 mg/1; AMPHETAMINE SULFATE 7.5 mg/1; DEXTROAMPHETAMINE SACCHARATE 7.5 mg/1; DEXTROAMPHETAMINE SULFATE 7.5 mg/1Jul 15, 2026Jul 15, 2026
Sandoz IncAMPHETAMINE ASPARTATE MONOHYDRATE 1.25 mg/1; AMPHETAMINE SULFATE 1.25 mg/1; DEXTROAMPHETAMINE SACCHARATE 1.25 mg/1; DEXTROAMPHETAMINE SULFATE 1.25 mg/1Jul 15, 2026Jul 15, 2026
Sandoz IncAMPHETAMINE ASPARTATE MONOHYDRATE 2.5 mg/1; AMPHETAMINE SULFATE 2.5 mg/1; DEXTROAMPHETAMINE SACCHARATE 2.5 mg/1; DEXTROAMPHETAMINE SULFATE 2.5 mg/1Jul 15, 2026Jul 15, 2026
Sandoz IncAMPHETAMINE ASPARTATE MONOHYDRATE 5 mg/1; AMPHETAMINE SULFATE 5 mg/1; DEXTROAMPHETAMINE SACCHARATE 5 mg/1; DEXTROAMPHETAMINE SULFATE 5 mg/1Jul 15, 2026Jul 15, 2026
Sandoz IncAMPHETAMINE ASPARTATE MONOHYDRATE 7.5 mg/1; AMPHETAMINE SULFATE 7.5 mg/1; DEXTROAMPHETAMINE SACCHARATE 7.5 mg/1; DEXTROAMPHETAMINE SULFATE 7.5 mg/1Jul 15, 2026Jul 15, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate — NDC 00185-0842-01," retrieved September 3, 2026, https://drugdashboards.com/drug/00185084201.

Free to cite with attribution — see how the data is put together.